Percheron Therapeutics LimitedASX: PER

Long COVID study identifies diagnostic & therapeutic targets

Aug 19, 2022 at 4:22 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment